Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1999;94:78-82
© 1999 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SANTIN, A. D.
Right arrow Articles by PARHAM, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SANTIN, A. D.
Right arrow Articles by PARHAM, G. P.

ORIGINAL RESEARCH

Secretion of Vascular Endothelial Growth Factor in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix

ALESSANDRO D. SANTIN, MD, PAUL L. HERMONAT, PhD, ANTONELLA RAVAGGI, PhD, SERGIO PECORELLI, MD, PhD, MARTIN J. CANNON, PhD and GROESBECK P. PARHAM, MD

From the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, and the Department of Microbiology and Immunology, University of Arkansas, Little Rock, Arkansas; and the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Brescia, Brescia, Italy.

Address reprint requests to: Alessandro D. Santin, MD, Division of Gynecologic Oncology, UAMS Medical Center, 4301 West Markham, Little Rock, AR 72205-7199

Objective: To determine whether major differences in vascular endothelial growth factor secretion exist between adenocarcinomas of the uterine cervix compared with squamous cell carcinomas.

Methods: The secretion of vascular endothelial growth factor by eight fresh cervical cancer cell preparations (four adenocarcinomas and four squamous cell carcinomas) and four established squamous cell lines was evaluated using a sensitive enzyme-linked immunosorbent assay in vitro.

Results: All cervical tumors secreted significant amounts of vascular endothelial growth factor, and no significant differences between fresh and established squamous cell lines were detectable. In contrast, a highly significant difference in vascular endothelial growth factor secretion was noted between fresh adenocarcinomas (mean = 2712, range between 1700 to 3500 pg/mL/105 cells/48 hours) when compared with fresh squamous (mean = 575, range between 200 to 950 pg/mL/105 cells/48 hours) or established squamous cervical carcinoma cell lines (mean = 712, range between 400 to 1000 pg/mL/105 cells/48 hours) (F-test, P <= .001).

Conclusion: These data strongly suggest that major differences in the secretion of vascular endothelial growth factor exist between squamous cell carcinoma and adenocarcinomas of the uterine cervix. Therefore, at least some of the differences in the natural biologic behavior of these two histologic types of cervical cancer, including the propensity for earlier lymphatic and hematogenous metastasis as well as the lower response to radiation treatment, could be related to major differences in the secretion of this powerful angiogenic and immunosuppressive cytokine.




This article has been cited by other articles:


Home page
J. Virol.Home page
A. D. Santin, P. L. Hermonat, A. Ravaggi, S. Bellone, S. Pecorelli, J. J. Roman, G. P. Parham, and M. J. Cannon
Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes
J. Virol., May 15, 2000; 74(10): 4729 - 4737.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Obstetricians and Gynecologists.